Active, Not Recruiting
Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC
NCT05401786
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Antoni van Leeuwenhoek - Netherlands Cancer Institute Amsterdam, North Holland, Netherlands